SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-020959
Filing Date
2023-04-27
Accepted
2023-04-27 16:20:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20008153x2_defa14a.htm DEFA14A 15394
2 ny20008153x2_nc1.jpg GRAPHIC 374652
3 ny20008153x2_nc2.jpg GRAPHIC 330970
  Complete submission text file 0001140361-23-020959.txt   988268
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39696 | Film No.: 23857295
SIC: 2836 Biological Products, (No Diagnostic Substances)